Aristo Bio-Tech, a company in the Pesticides & Agrochemicals industry, reported revenue of ₹198 crore and net profit of ₹5.00 crore for the September 2026 quarter.
Aristo Bio-Tech (NSE: ARISTO-SM) closed at ₹123.00 on 20 Nov 2026. Its market capitalisation is ₹84 crore and it trades at 11.7 times earnings.
Incorporated in 2005, Aristo Bio-Tech and Lifescience Ltd manufactures and supplies pesticides and agrochemicals
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.